This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $845 | Check With Us |
250mg | $1550 | Check With Us |
500mg | $2325 | Check With Us |
Cat #: V1875 CAS #: 918633-87-1 Purity ≥ 98%
Description: Evofosfamide (TH-302) is potent and selective hypoxia-activated prodrug targeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 449.04 |
---|---|
Molecular Formula | C9H16Br2N5O4P |
CAS No. | 918633-87-1 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 90 mg/mL (200.4 mM)r |
Water: 10 mg/mL (22.3 mM)r | |
Ethanol: 90 mg/mL (200.4 mM) | |
Solubility In Vivo | 30% Propylene glycol, 5% Tween 80, 65% D5W: 30 mg/mL |
SMILES Code | O=P(NCCBr)(NCCBr)OCC1=CN=C([N+]([O-])=O)N1C |
Synonyms | TH302; TH 302; TH-302 |
Protocol | In Vitro | Evofosfamide (TH-302) induces γH2AX and apoptosis. Evofosfamide displays hypoxia-selective and concentration-dependent cytotoxic activity that is comparable in both p53-proficient and -deficient cells. Treatment with Evofosfamide (TH-302) alone causes an accumulation of G2/M cells. Inhibition of Chk1 by PF47736 in cells treated with Evofosfamide reduces Evofosfamide (TH-302)-mediated G2/M arrest under both normoxia and hypoxia. |
---|---|---|
In Vivo | Evofosfamide (TH-302) is a hypoxia-activated prodrug known to activate selectively under the hypoxic conditions commonly found in solid tumors. The mean values of normalized Ktrans decrease 69.2% for Evofosfamide (TH-302)-treated mice in Hs766t tumors, decrease 46.1% for Mia PaCa-2 tumors and increase 4.9% in SU.86.86 tumors. Both changes for Hs766t and Mia PaCa-2 treatment groups are statistically significant (P<0.01) when compare to their own control group. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.2270 mL | 11.1349 mL | 22.2697 mL | 44.5395 mL |
5mM | 0.4454 mL | 2.2270 mL | 4.4539 mL | 8.9079 mL |
10mM | 0.2227 mL | 1.1135 mL | 2.2270 mL | 4.4539 mL |
20mM | 0.1113 mL | 0.5567 mL | 1.1135 mL | 2.2270 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.